Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Fourth-generation EGFR tyrosine kinase inhibitor

US Patent 11286261 · Granted Mar 29, 2022

Estimated economic value: $119,000

Assignee

Inventors

View full patent text on Google Patents →